Poznan University of Medical Sciences
Poznan, Poznań, 61-701, Poland
NCT Number: NCT06083428
Effect of PENG block and ESPB on pain management, and NLR and PLR following knee arthroplasty
Looking for future studies?
Notify Me20 year–90 year
All sexes
Interventional
Phase 4
Poznan, Poznań, 61-701, Poland
Hip arthroplasty is one of the most common orthopedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prosthesis. Regional anesthesia methods may be performed to reduce the inflammatory response, opioid consumption, and opioid-related side effects.
In recent years, the influence of regional anesthesiology on reducing the inflammatory response after surgical procedures has been emphasized. However, very few studies have evaluated the effect of various methods of anesthesia on the NLR.
This is the first study to investigate the effect of regional anesthesia on the NLR and PLR in patients undergoing hip replacement surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ultrasound guided ESPB - L4 level, unilateral
Other names: Erector Spinae Plane Block
ultrasound guided PENG block
Other names: PENG block
Only spinal anesthesia
Other names: No peripheral nerve block
Time frame: 48 hours after surgery
Total opiate consumption after surgery
Time frame: 48 hours after procedure
Time after surgery when the patient needs opiate for the first time
Time frame: 4 hours after surgery
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 8 hours after surgery
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 12 hours after surgery
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 18 hours after surgery
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 24 hours after surgery
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 36 hours after surgery
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 48 hours after surgery
Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)
Time frame: 24 hours after surgery
Neutrophil-to-lymphocyte ratio
Time frame: 48 hours after surgery
Neutrophil-to-lymphocyte ratio
Time frame: 24 hours after surgery
Platelet-to-lymphocyte ratio
Time frame: 48 hours after surgery
Platelet-to-lymphocyte ratio
Time frame: Postoperative 24 hours period
Quadriceps muscle strength (knee extension and hip adduction) will be evaluated according to the medical research council muscle strength rating
Poznan University of Medical Sciences
Other
Erector Spinae Plane Block (ESPB) vs. PENG Block for Pain Management and Stress Response in Patients Undergoing Total Hip Arthroplasty. A Prospective, Randomized Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07023107
Arthritis, Hip Arthropathy
Poznan, Poland
View Trial DetailsNCT06470139
Arthritis, Hip Arthropathy
Poznan, Poznań, Poland
View Trial DetailsNCT05944380
Agnosia, Arthritis
Poznan, Wielkopolska, Poland
View Trial DetailsNCT07180979
Arthritis, Hip Arthropathy
Poznan, Poland
View Trial Details